BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8358895)

  • 1. Ovulation induction in gonadotrophin-resistant women.
    Homburg R
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):349-61. PubMed ID: 8358895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
    Homburg R; Levy T; Ben-Rafael Z
    Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fertilisation. A review of drug therapy and clinical management.
    Jennings JC; Moreland K; Peterson CM
    Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC; Donderwinkel P; Schoot DC
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.
    Awonuga AO; Nabi A
    J Assist Reprod Genet; 1997 Oct; 14(9):503-7. PubMed ID: 9401867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and ovulation: is there an indication for treatment of infertile women with growth hormone?
    Jacobs HS
    Horm Res; 1992; 38 Suppl 1():14-21. PubMed ID: 1295808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovulation stimulation and induction.
    Blacker CM
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):57-84. PubMed ID: 1576983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy.
    Ho Yuen B; Pride SM; Sime MO
    Am J Obstet Gynecol; 1984 Mar; 148(5):508-12. PubMed ID: 6422760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with gonadotrophin releasing hormone agonist and gonadotrophins in poor responders to hyperstimulation for in vitro fertilization (IVF): clinical and endocrine results.
    McKenna KM; Foster P; McBain J; Martin M; Johnston WI
    Aust N Z J Obstet Gynaecol; 1989 Nov; 29(4):428-32. PubMed ID: 2517193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
    Wang Y; Kuang Y; Chen Q; Cai R
    Trials; 2018 Aug; 19(1):455. PubMed ID: 30134964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superovulation strategy before in vitro fertilization.
    Hillier SG; Afnan AM; Margara RA; Winston RM
    Clin Obstet Gynaecol; 1985 Sep; 12(3):687-723. PubMed ID: 3933880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
    Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
    Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of gonadotrophin preparations.
    Ledger W
    Reprod Biomed Online; 2005 Jun; 10 Suppl 3():19-24. PubMed ID: 23577411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation induction protocols.
    Meldrum DR
    Arch Pathol Lab Med; 1992 Apr; 116(4):406-9. PubMed ID: 1558480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.
    Dor J; Seidman DS; Amudai E; Bider D; Levran D; Mashiach S
    Hum Reprod; 1995 Jan; 10(1):40-3. PubMed ID: 7745068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization.
    Gibreel A; Maheshwari A; Bhattacharya S
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008528. PubMed ID: 23152261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT.
    Smitz J; Devroey P; Camus M; Deschacht J; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1988 Jul; 3(5):585-90. PubMed ID: 3139698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.